Sep 30, 2017

United Therapeutics Q3 2017 Earnings Report

Total Revenue
$446M
Previous year: $408M
+9.1%
EPS
$4.69
Previous year: $4.36
+7.6%
Gross Profit
$426M
Previous year: $385M
+10.8%
Cash and Equivalents
$1.07B
Previous year: $953M
+12.0%
Free Cash Flow
$237M
Previous year: $220M
+7.7%
Total Assets
$2.94B
Previous year: $2.27B
+29.4%

United Therapeutics

United Therapeutics